2Curcumin and Apigenin - novel and promising therapeutics against chronic neuroinlfammation in Alzheimer’s disease1181-1185
3Neuroimmunomodulatory effects of transcranial laser therapy combined with intravenous tPA administration for acute cerebral ischemic injury1186-1190
5A case to be made：theoretical and empirical arguments for the need to consider fatigue in post-stroke motor rehabilitation1195-1197
7The neuroprotective effects of human growth hormone as a potential treatment for amyotrophic lateral sclerosis1201-1203
8The vascular stem cell niche:roadmap for transplanted neural progenitor cells during environmental enrichment?1204-1205
12Fractalkine：multiple strategies to counteract glutamate receptors activation leading to neuroprotection1214-1215
15The neuroprotective effects of (S)-3,5-dihydroxyphenylglycine preconditioning in middle cerebral artery occluded rats：a perspective as a contrivance for stroke1221-1222
16Nogo-A and its functions beyond axonal inhibition：the controversial role of Nogo-A in Parkinson’s disease1223-1224
18Identifying speciifc RGC types may shed light on their idiosyncratic responses to neuroprotection1228-1230
19A new tool for monitoring brain function：eye tracking goes beyond assessing attention to measuring central nervous system physiology1231-1233
20Central plasticity resulting from chronic low back pain in degenerative disorders of the spine1234-1236
